If it helps manage and prevent those life-threatening risks, then for that patient it is probably better to continue it. The TGA said it first became aware of the link to NAION in 2024 after a study published in a peer-reviewed medical journal raised concerns, and further evidence of the potential links has since been closely monitored
When taking semaglutide for weight loss, you can expect to see changes very soon
NICE guidance supports the use of GLP-1 receptor agonists for type 2 diabetes (NG28) when certain criteria are met, typically after other treatments have been tried
Weight stabilizes
Cell Reports Medicine , 6(7), 102214
In the ELIXA [66], EXSCEL [68], and PIONEER 6 [67,71] studies, treatments of exenatide twice-daily, exenatide once-weekly, and oral semaglutide groups were non-inferior to placebo in terms of CV disease safety, respectively